Aevi genomic medicine, inc. (GNMX)
Income statement / TTM
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Research and development expenses

-

15,394

18,907

22,299

-

23,870

23,790

25,176

25,048

26,474

29,548

28,552

28,846

25,689

21,406

18,356

17,039

14,752

12,249

10,490

8,692

8,863

8,981

8,870

8,618

8,060

7,626

7,187

6,609

6,500

6,405

5,987

5,514

4,540

0

0

0

Less: Participation by the Office of the Chief Scientist

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

0

0

-

1,573

1,314

1,488

734

1,756

1,769

1,843

1,882

860

1,051

841

0

0

0

U.S. Government grant

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

0

0

0

0

0

0

Participation by third party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

75

75

75

460

120

0

0

0

Research and development expenses

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

15,444

12,695

9,267

0

-

0

0

-

7,297

7,304

6,572

6,892

5,431

4,840

4,582

4,448

5,052

4,003

3,049

0

0

0

Non-recurring research and development expenses resulting from acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,170

8,170

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative expenses

6,454

7,085

8,174

8,663

8,749

8,845

8,710

9,524

10,972

11,744

12,320

13,523

12,300

12,254

13,198

12,954

13,256

12,565

11,540

10,686

12,088

12,344

11,068

10,521

8,289

7,198

8,384

7,197

6,818

7,225

5,503

4,924

6,325

4,889

0

0

0

Excess amount of participation in research and development from third party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

0

734

46

0

0

0

Operating loss

-19,222

-22,479

-27,081

-30,962

-31,445

-32,715

-32,500

-34,700

-36,020

-38,022

-41,672

-41,879

-39,835

-44,631

-39,862

-36,568

-36,329

-24,832

-21,552

-18,939

-18,636

-19,670

-18,476

-17,818

-15,593

-13,770

-15,276

-12,628

-11,658

-11,807

-9,951

-9,976

-9,594

-6,516

0

0

0

Financial income, net

0

0

0

-

0

0

0

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financial expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,299

1,945

817

1,026

68

1,661

1,622

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Financial income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

892

564

1,416

588

586

935

410

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Financial expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

4,040

4,272

0

-

0

0

-

-

-

Financial income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

164

113

0

-

0

0

-

-

-

Financial expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Financial income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Loss before taxes on income

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-18,421

-17,425

-20,530

-18,788

-17,112

-14,326

-11,209

-16,016

-15,052

-14,653

-15,050

-10,467

-8,093

-9,688

0

0

0

-

Income (loss) before taxes on income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Taxes on income

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

12

20

18

19

17

15

16

22

19

9

9

3

3

3

0

0

-

0

Net loss

-19,152

-22,359

-26,905

-30,775

-31,308

-32,664

-32,506

-34,714

-36,038

-38,003

-41,677

-41,904

-39,884

-45,835

-40,214

-37,992

-37,725

-24,244

-21,998

-18,433

-17,445

-20,548

-18,807

-17,129

-14,341

-11,225

-16,038

-15,071

-14,662

-15,059

-10,470

-8,096

-9,691

-8,218

0

0

0

Basic and diluted loss per share

-0.06

-0.06

-0.07

-

-0.12

-0.14

-0.15

-

-

-

-

-

-0.29

-0.35

-0.34

-

-

-

-

-

-

-

-0.28

-

-

-

-

-

-0.25

-

-

-

-0.35

-0.26

-0.06

-0.80

-

Weighted average number of common stock used in computing basic and diluted loss per share

-

-

-

-

-

-

-

-

-

-

-

-

37,080

33,469

32,953

-

-

-

-

-

-

-

18,872

-

-

-

-

-

-

-

-

-

9,657

9,033

-

-

-

Basic loss per share

-

-

-

-0.10

-

-

-

-0.13

-0.23

-0.22

-0.29

-

-

-

-

-0.20

-0.66

-0.24

-0.36

-

-0.16

-0.21

-

-0.29

-0.33

-0.11

-0.24

-

-

-0.69

-0.28

-

-

-

-

-

-0.47

Diluted loss per share

-

-

-

-0.10

-

-

-

-0.13

-0.23

-0.22

-0.29

-

-

-

-

-0.20

-0.66

-0.28

-0.36

-

-0.21

-0.21

-

-0.33

-0.33

-0.11

-0.29

-

-

-0.69

-0.28

-

-

-

-

-

-0.47

Weighted average number of common stock used in computing basic and diluted loss per share

64,766

64,766

64,766

64,766

62,019

59,338

59,334

55,225

37,110

37,110

37,108

-

-

-

-

32,339

24,982

24,906

24,843

-

18,817

18,715

-

18,473

18,410

18,410

15,222

12,295

12,013

10,032

9,753

-

-

-

-

-

4,133

Weighted average number of shares of common stock used in computing diluted loss per share

-

-

-

64,766

-

-

-

55,225

37,110

37,110

37,108

-

-

-

-

32,339

24,982

25,094

24,843

-

18,938

18,715

-

18,277

18,410

18,410

15,634

12,295

12,013

10,032

9,753

-

-

-

-

-

4,133

Weighted average number of Common stock used in computing basic and diluted loss per share (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,370

4,534

-